The Study
KLF3 impacts insulin sensitivity and glucose uptake in skeletal muscle.
This study is like playing with a toy car in a lab to see what happens when you push a button—it shows that changing one part (KLF3) changes how the car moves (glucose uptake). But it doesn’t prove that the same thing will happen in real cars (human bodies) or that it can fix broken cars (diabetes).
Analysis score
Maximum 58 for a case-control study.
Where the score came from
Scientists found a protein called KLF3 that acts like a brake on how well muscle cells take in sugar from the blood. When they turned down this brake, muscles took in more sugar — even better with insulin.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 514 / 100
Quality score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — since muscles handle 80% of sugar after meals, reducing KLF3 could help people with type 2 diabetes control blood sugar better.
- 2Turning down KLF3 made muscle cells take in 20% more sugar at rest and 40–50% more insulin-stimulated sugar.
- 3Turning up KLF3 made them take in 15% less sugar.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
American journal of physiology. Cell physiology
Year
2024
Authors
Shuying Fu, Xiaocheng Gong, Keying Liang, Ke Ding, Li Qiu, Huice Cen, Hongli Du
Related Content
Claims (6)
After eating, skeletal muscle removes the majority of glucose from the blood, which lowers blood sugar levels and reduces the amount of fat stored in the body.
In rat muscle cells, lowering KLF3 protein levels increases glucose uptake under both normal and insulin-stimulated conditions by about 20% and improves insulin sensitivity by increasing the levels of GLUT4, AKT, and insulin receptor proteins and enhancing specific phosphorylation events in AKT and TBC1D1/TBC1D4.
In diabetic rats, KLF3 protein levels are higher in muscle tissue than in healthy rats, and exercise lowers these levels, which is associated with better blood sugar regulation and improved insulin response.
In rat muscle cells exposed to insulin, reducing KLF3 protein levels increases AKT phosphorylation at two specific sites and moves more GLUT4 to the cell membrane.
In rat muscle cells, increasing the amount of KLF3 protein decreases glucose uptake in response to insulin and reduces levels of key insulin signaling proteins while increasing levels of inhibitory proteins, leading to reduced insulin pathway activity.
In rat muscle cells exposed to insulin, reducing the amount of KLF3 protein increases the phosphorylation of TBC1D1 and TBC1D4 at specific sites by 30–40%, without changing the total amount of these proteins.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.